Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup Study.

scientific article published in April 1986

Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup Study. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID3516395

P2093author name stringGoldberg J
Gottlieb AJ
Preisler HD
Brennan J
Rai K
Winton EF
Miller KB
Browman G
Vogler WR
Grunwald H
P433issue4
P921main subjectcytarabineQ180983
P304page(s)455-459
P577publication date1986-04-01
P1433published inCancer Treatment ReportsQ27710285
P1476titleRandomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup Study
P478volume70

Reverse relations

cites work (P2860)
Q37717088Cytosine arabinoside in the treatment of acute myeloid leukemia: the role and place of high-dose regimens
Q46274818Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation
Q44503375Five-day 4'-(9-acridinylamino)methanesulphon-m-anisidide and intermediate-dose cytosine arabinoside in high-risk relapsing or refractory acute myeloid leukemia
Q33383996High-dose ara-C and etoposide in refractory or relapsing acute leukemia
Q37904928The toxicity of cytarabine
Q37909059Treatment strategies in acute myeloid leukemia (AML). B. Second line treatment